14 Aug 2024 --- Skin care innovator Crown Laboratories and biotech specialist Revance Therapeutics enter a merger agreement that will combine their skin care and aesthetics portfolios. Upon completion of the transaction, Crown Laboratories will integrate a portfolio of more than ten “cutting-edge” skin health and aesthetic brands, and one of the largest distribution footprints in skin care across medical, retail and e-commerce channels.
